Affiliations
AffiliationsItem in Clipboard
Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverageJanet S de Moor et al. Prev Med. 2018 Jul.
doi: 10.1016/j.ypmed.2018.05.001. Epub 2018 May 3. Authors Janet S de Moor 1 , Robin A Cohen 2 , Jean A Shapiro 3 , Marion R Nadel 3 , Susan A Sabatino 3 , K Robin Yabroff 4 , Stacey Fedewa 5 , Richard Lee 6 , V Paul Doria-Rose 4 , Cheryl Altice 4 , Carrie N Klabunde 7 AffiliationsItem in Clipboard
AbstractRegular colorectal cancer (CRC) screening is recommended for reducing CRC incidence and mortality. This paper provides an updated analysis of CRC screening in the United States (US) and examines CRC screening by several features of health insurance coverage. Recommendation-consistent CRC screening was calculated for adults aged 50-75 in 2008, 2010, 2013 and 2015 using data from the National Health Interview Survey. CRC screening prevalence in 2015 was described overall and by sociodemographic subgroups. CRC screening by health insurance coverage was further examined using multivariable logistic regression, stratified by age (50-64 years and 65-75 years) and adjusted for age, race/ethnicity, sex, education, income, time in US, and comorbid conditions. Recommendation-consistent screening increased from 51.6% in 2008 to 58.3% in 2010 (p < 0.001). Use plateaued from 2010 to 2013 but increased to 61.3% in 2015 (p < 0.001). In 2015, adults aged 50-64 years with traditional employer-sponsored private insurance were more likely to be screened (62.2%) than those with traditional private direct purchase plans (50.9%) and the uninsured (24.8%) (p < 0.01, respectively). After multivariable adjustment, differences between traditional employer-sponsored private insurance and the uninsured remained statistically significant. Adults aged 65-75 with Medicare and private insurance were more likely to be screened (76.3%) than those with Medicare, no supplemental insurance (68.8%) or Medicare and Medicaid (65.2%) (p < 0.001). After multivariable adjustment, the differences between Medicare and private insurance and Medicare no supplemental insurance remained statistically significant. CRC screening rates have increased over time, but certain segments of the population, especially the uninsured, continue to screen below recommended levels.
Keywords: Colorectal cancer; Insurance coverage; Screening.
Copyright © 2018. Published by Elsevier Inc.
Conflict of interest statementThe authors declare there is no conflict of interest. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Department of Health and Human Services.
FiguresFig. 1.
Percentage of Adults Aged 50–75…
Fig. 1.
Percentage of Adults Aged 50–75 Receiving Recommendation-Consistent Colorectal Cancer Screening, 2008–2015 Estimates were…
Fig. 1.Percentage of Adults Aged 50–75 Receiving Recommendation-Consistent Colorectal Cancer Screening, 2008–2015 Estimates were age-adjusted using the 2000 U.S. standard population by 5-year age groups. Recommendation-consistent screening was defined as home FOBT within the past year, sigmoidoscopy within the past 5 years and fecal occult blood testing (FOBT) within the past 3 years, or colonoscopy within the past 10 years. Percentages were weighted to account for the complex design of NHIS. Error bars are 95% confidence intervals. Numbers in bold text are significantly different (p < 0.05) from the previous assessment year. Overall differences between 2008 and 2015 were statistically significant (p < 0.05) for screening within recommendations, colonoscopy, and FOBT.
Fig. 2.
a: Recommendation-consistent colorectal cancer screening…
Fig. 2.
a: Recommendation-consistent colorectal cancer screening in 2015 by type of health insurance among…
Fig. 2.a: Recommendation-consistent colorectal cancer screening in 2015 by type of health insurance among adults ages 50–64 years. Estimates were age adjusted to the 2000 United States standard population by 5-year age groups. Screening within recommendations was defined as home FOBT within the past year, sigmoidoscopy within the past 5 years and FOBT within the past 3 years, or colonoscopy within the past 10 years. Employer-sponsored insurance also includes insurance obtained through a union. Directly purchased private health insurance includes private plans obtained through the Health Insurance Marketplace, school, or other means. Other public plans include insurance classified as public only, other government only and SCHIP. Military coverage includes coverage through TRICARE, VA, and Champ-VA. Military coverage is restricted to civilians only and includes those with military coverage and Medicare disability. Predicted probabilities (adjusted percentages) were derived from multivariable logistic regression analyses adjusting for age, sex, race/ethnicity, education, income as a proportion of the federal poverty line, comorbidity, and years in the US. Error bars represent 95% confidence intervals. All estimates were weighted to account for the complex survey design of NHIS. * Statistically significant difference (p < 0.05) in age-adjusted analysis compared to traditional employer-sponsored private insurance. + Statistically significant difference (p < 0.05) in multivariable-adjusted analyses compared to traditional employer-sponsored private insurance. b: Recommendation-consistent colorectal cancer screening in 2015 by type of health insurance among adults aged 65–75 years Estimates were age adjusted to the 2000 United States standard population by 5-year age groups. Screening within recommendations was defined as home FOBT within the past year, sigmoidoscopy within the past 5 years and FOBT within the past 3 years, or colonoscopy within the past 10 years. Medicare and private includes adults with only private insurance. Medicaid or any public includes other state-sponsored health plans. Predicted probabilities (adjusted percentages) were derived from multivariate logistic regression analyses adjusting for age, sex, race/ethnicity, education, income as a proportion of the federal poverty line, comorbidity, and years in the US. Error bars represent 95% confidence intervals. All estimates were weighted to account for the complex survey design of NHIS. *Statistically significant difference (p < 0.05) in age-adjusted analysis compared to Medicare and private. + Statistically significant difference (p < 0.05) in multivariable-adjusted analyses compared to Medicare and private.
Similar articlesGan T, Sinner HF, Walling SC, Chen Q, Huang B, Tucker TC, Patel JA, Evers BM, Bhakta AS. Gan T, et al. J Am Coll Surg. 2019 Apr;228(4):342-353.e1. doi: 10.1016/j.jamcollsurg.2018.12.035. Epub 2019 Feb 22. J Am Coll Surg. 2019. PMID: 30802505 Free PMC article.
Wray CM, Khare M, Keyhani S. Wray CM, et al. JAMA Netw Open. 2021 Jun 1;4(6):e2110275. doi: 10.1001/jamanetworkopen.2021.10275. JAMA Netw Open. 2021. PMID: 34061204 Free PMC article.
Tsai MH, Xirasagar S, Li YJ, de Groen PC. Tsai MH, et al. Prev Chronic Dis. 2015 May 21;12:E80. doi: 10.5888/pcd12.140533. Prev Chronic Dis. 2015. PMID: 25996988 Free PMC article.
Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM. Schneider EC, et al. Med Care. 2008 Sep;46(9 Suppl 1):S84-90. doi: 10.1097/MLR.0b013e31817fdf80. Med Care. 2008. PMID: 18725838
May FP, Yano EM, Provenzale D, Neil Steers W, Washington DL. May FP, et al. Dig Dis Sci. 2017 Aug;62(8):1923-1932. doi: 10.1007/s10620-017-4607-x. Epub 2017 May 20. Dig Dis Sci. 2017. PMID: 28528373
Tepus M, Yau TO. Tepus M, et al. Gastrointest Tumors. 2020 Jul;7(3):62-73. doi: 10.1159/000507701. Epub 2020 May 20. Gastrointest Tumors. 2020. PMID: 32903904 Free PMC article. Review.
Sun W, Cheng M, Zhuang S, Qiu Z. Sun W, et al. Med Sci Monit. 2019 Apr 2;25:2397-2418. doi: 10.12659/MSM.913282. Med Sci Monit. 2019. PMID: 30939127 Free PMC article.
Hicklin K, O'Leary MC, Nambiar S, Mayorga ME, Wheeler SB, Davis MM, Richardson LC, Tangka FKL, Lich KH. Hicklin K, et al. Prev Med. 2022 Sep;162:107126. doi: 10.1016/j.ypmed.2022.107126. Epub 2022 Jul 3. Prev Med. 2022. PMID: 35787844 Free PMC article.
Coury J, Miech EJ, Styer P, Petrik AF, Coates KE, Green BB, Baldwin LM, Shapiro JA, Coronado GD. Coury J, et al. Implement Sci Commun. 2021 Jan 11;2(1):5. doi: 10.1186/s43058-020-00104-7. Implement Sci Commun. 2021. PMID: 33431063 Free PMC article.
Shapiro JA, Soman AV, Berkowitz Z, Fedewa SA, Sabatino SA, de Moor JS, Clarke TC, Doria-Rose VP, Breslau ES, Jemal A, Nadel MR. Shapiro JA, et al. Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1554-1565. doi: 10.1158/1055-9965.EPI-20-1809. Epub 2021 Jun 4. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34088751 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3